Soma and Propulsid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Soma (carisoprodol) and Propulsid (cisapride monohydrate). Common drug interactions include cardiac failure congestive among females and oedema lower limb among males.

The phase IV clinical study analyzes what interactions people have when they take Soma and Propulsid. It is created by eHealthMe based on reports of 51 people who take the same drugs from the FDA, and is updated regularly.

What is Soma?

Soma has active ingredients of carisoprodol. It is often used in muscle spasms. eHealthMe is studying from 17,137 Soma users. Check the latest studies of Soma.

What is Propulsid?

Propulsid has active ingredients of cisapride monohydrate. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 8,130 Propulsid users. Check the latest studies of Propulsid.



On Jul, 20, 2026

51 people who take Soma and Propulsid together, and have interactions are studied.

Soma and Propulsid drug interactions.

What are the common drug interactions of Soma and Propulsid, by gender? *:

female:

  1. Cardiac failure congestive
  2. Chest pain
  3. Hypertension (high blood pressure)
  4. Weight decreased
  5. Abdominal pain
  6. Dehydration (dryness resulting from the removal of water)
  7. Diarrhoea
  8. Drug dependence
  9. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
  10. Hypokalaemia (low potassium)

male:

  1. Oedema lower limb (fluid collection in tissue of lower leg)
  2. Chest pain
  3. Depression
  4. Pulmonary embolism (blockage of the main artery of the lung)
  5. Tremor (trembling or shaking movements in one or more parts of your body)
  6. Venous thrombosis deep limb (blood clot that forms in a vein deep in the limb)
  7. Appetite increased (increased appetite is when you want to eat much more often or in larger quantities than your body requires)
  8. Application site reaction
  9. Arrhythmia (irregular heartbeat)
  10. Blood glucose fluctuation

What are the common drug interactions of Soma and Propulsid, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Drug dependence
  2. Abdominal pain
  3. Aggression
  4. Agitation (state of anxiety or nervous excitement)
  5. Anxiety
  6. Asthma
  7. Depression
  8. Dizziness
  9. Drug abuser
  10. Irritability

30-39:

  1. Migraine (headache)
  2. Abdominal pain
  3. Alcoholism (problems with alcohol)
  4. Cellulitis (infection under the skin)
  5. Dependence
  6. Diarrhoea
  7. Difficulty in walking
  8. Diplopia (double vision)
  9. Drug effect decreased
  10. Dyspnoea (difficult or laboured respiration)

40-49:

  1. Electrocardiogram qt prolonged
  2. Electrolyte imbalance
  3. Dyspnoea (difficult or laboured respiration)
  4. Oedema lower limb (fluid collection in tissue of lower leg)
  5. Anxiety
  6. Blood glucose fluctuation
  7. Chest pain
  8. Cholecystitis infective (infection of gallbladder capable to infect other organs)
  9. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  10. Fatigue (feeling of tiredness)

50-59:

  1. Depression
  2. Distress
  3. Electrocardiogram qt corrected interval prolonged
  4. Erythema (redness of the skin)
  5. Fall
  6. Haematocrit decreased
  7. Haemoglobin decreased
  8. Heart rate increased
  9. Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
  10. Hypertension (high blood pressure)

60+:

  1. Appetite increased (increased appetite is when you want to eat much more often or in larger quantities than your body requires)
  2. Cardiac failure congestive
  3. Pulmonary embolism (blockage of the main artery of the lung)
  4. Pulmonary oedema (fluid accumulation in the lungs)
  5. Venous thrombosis deep limb (blood clot that forms in a vein deep in the limb)
  6. Abdominal discomfort
  7. Abdominal distension
  8. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  9. Angiopathy (generic term for a disease of the blood vessels)
  10. Asthenia (weakness)

What are the existing conditions these people have? *

  1. Hyperlipidaemia (presence of excess lipids in the blood): 4 people, 7.84%
  2. Gastrointestinal Disorder (functional problems of gastrointestinal tract): 4 people, 7.84%
  3. Back Pain: 4 people, 7.84%
  4. Hypokalemia (low potassium): 3 people, 5.88%
  5. Diabetes: 3 people, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Soma and Propulsid?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Soma and Propulsid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Soma:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Propulsid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Soma and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Propulsid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on carisoprodol and cisapride monohydrate (the active ingredients of Soma and Propulsid, respectively), and Soma and Propulsid (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: